News

Medipharm Reminds Shareholders To Vote In Advance Of June 13 Deadline
Shareholders Urged to Vote for Proven Strategy and Team, Reject Dissident's Inadequate Plan and NomineesTORONTO, June 11, 2025 (GLOBE NEWSW ...
The American Journal of Managed Care11h
FDA Approves Tablet Formulation of Zanubrutinib for All Indications
The tablet formulation of zanubrutinib (Brukinsa; BeOne) is now approved for all 5 indications across several hematological ...
Liquidia: Competitor Insmed's Stunning PAH Data Arrives At Precisely The Wrong Time
Liquidia finally launched Yutrepia after years of legal battles, but faces entrenched competition from United Therapeutics' ...
CURE15h
FDA Approves Ibtrozi for ROS1+ Advanced Non-Small Cell Lung Cancer
The U.S. FDA has approved treatment with Ibtrozi for patients with locally advanced or metastatic ROS1-positive non-small ...
7 of the riskiest dietary and herbal supplements on the market, according to doctors
These popular dietary and herbal supplements can cause serious side effects in high doses, dangerous drug interactions, and more, doctors warn.
Le Lézard16h
MoEngage Recognized as "Customers' Choice" in Gartner Peer Insightstm Voice of the Customer for Multichannel Marketing Hubs
MoEngage, a leading customer engagement platform, is thrilled to announce its recognition as a "Customers' Choice" vendor in the latest Gartner Peer Insights(tm) Voice of the Customer: Multichannel ...
InnovationRx: RFK Jr. Purges The Vaccine Advisory Committee
In this week’s edition of InnovationRx, we look at RFK Jr.’s vaccine advisory committee purge, a tech billionaire’s funding ...
Targeted Oncology17h
FDA Grants Fast Track Designation to RAD101 for Imaging of Recurrent Brain Metastases
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Healio18h
Liver cleanses ‘not uniformly harmful’ but ‘not uniformly safe’
Liver cleanse products are growing in popularity, despite little evidence showing benefit.“The idea of a liver cleanse is ...
These are the best hair growth products for men, according to hair loss experts
Whether you want a medicated solution or an all-natural fix, these pro-backed recommendations can start helping in as little ...
Thiogenesis Announces FDA Clearance of its Investigational New Drug Application ("IND") for a Phase 2a Clinical Trial in Leigh Syndrome Spectrum
June 11, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ('Thiogenesis' or the 'Company') a clinical-stage biotechnology company developing disulfides that drive the production of ...